Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants. — Read on http://www.principletrial.org/news/asthma-drug-budesonide-shortens-recovery-time-in-non-hospitalised-patients-with-covid-19/

b-s-h.org.uk/media/19530/guidance-version-13-on-mngmt-of-thrombosis-with-thrombocytopenia-occurring-after-c-19-vaccine_20210407.pdf

Persistent symptoms up to four months after community and hospital‐managed SARS‐CoV‐2 infection | The Medical Journal of Australia — Read on http://www.mja.com.au/journal/2021/214/6/persistent-symptoms-four-months-after-community-and-hospital-managed-sars-cov-2

Suspected Vaccine Induced Prothrombotic Immune Thrombocytopenia (VIPIT): THANZ Advisory Statement — Read on http://www.thanz.org.au/news/suspected-vaccine-induced-prothrombotic-immune-thrombocytopenia-vipit-thanz-advisory-statement-check-for-weekly-updates